Sara Nørgaard Søgaard

Dr. Sara Nørgaard Søgaard

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
MCMariana Bichuette Cartuliares
Mariana Bichuette Cartuliares
SSSara Nørgaard Søgaard
Sara Nørgaard Søgaard
FRFlemming S. Rosenvinge
Flemming S. Rosenvinge
CMChristian B. Mogensen
Christian B. Mogensen
MHMathias Amdi Hertz
Mathias Amdi Hertz
HSHelene Skjøt-Arkil
Helene Skjøt-Arkil
Background: Denmark has a low level of antimicrobial resistance (AMR). Patients hospitalized with suspected infection often present with unspecific symptoms. This challenges the physician between using narrow-spectrum antibiotics in accordance with guidelines or broad-spectrum antibiotics to compensate for diagnostic uncertainty. The aim of this study was to investigate adherence to a restrictive antibiotic guideline for the most common infection in emergency departments (EDs), namely community-acquired pneumonia (CAP). Method: This multicenter descriptive cross-sectional study included adults admitted to Danish EDs with a suspected infection. Data were collected prospectively from medical records. Results: We included 954 patients in the analysis. The most prescribed antibiotics were penicillin with beta-lactamase inhibitor at 4 h (307 (32.2%)), 48 h (289 (30.3%)), and day 5 after admission (218 (22.9%)). The empirical antibiotic treatment guidelines for CAP were followed for 126 (31.3%) of the CAP patients. At 4 h, antibiotics were administered intravenously to 244 (60.7%) of the CAP patients. At day 5, 218 (54.4%) received oral antibiotics. Conclusion: Adherence to CAP guidelines was poor. In a country with a restrictive antibiotic policy, infections are commonly treated with broad-spectrum antibiotics against recommendations.

2 July 2026 in JAC-Antimicrobial Resistance
Verified
Journal Article
Open access
SSSara Nørgaard Søgaard
Sara Nørgaard Søgaard
LWLogan Ward
Logan Ward
MMMads Lause Mogensen
Mads Lause Mogensen
CMChristian B Mogensen
Christian B Mogensen
MCMariana Bichuette Cartuliares
Mariana Bichuette Cartuliares
HSHelene Skjøt-Arkil
Helene Skjøt-Arkil
Background and objectives: Antimicrobial resistance remains a global health challenge despite the WHO AWaRe framework promoting responsible antibiotic use. Adherence to clinical guidelines, particularly during initial empirical prescribing in the emergency department (ED), is crucial. The clinical decision-support system (CDSS), integrating clinical and laboratory data, aims to improve evidence-based therapy and guideline adherence. To evaluate whether a CDSS can improve adherence to antibiotic guidelines in ED patients with suspected infections and its effect on prescribing according to WHO AWaRe classification. Methods: We retrospectively analysed 756 adults with confirmed infection from a multicentre cohort study in Southern Denmark. Expert diagnoses were mapped to the CDSS TREAT-Essential, which recommended empirical antibiotics based on illness severity, local guidelines and patient-specific factors. Empirical therapy was defined as antibiotics administered within 4 hours of ED arrival. Outcomes included guideline adherence and division in relation to WHO AWaRe classification. Adherence was defined as either CDSS-recommended or physician-prescribed antibiotics according to each patient’s diagnosis. Data were compared using McNemar’s χ2 and Wilcoxon signed-rank tests. Results: Clinicians prescribed empiric antibiotics to fewer patients than recommended by the CDSS or guidelines (P < 0.001), fewer combination therapies (P < 0.001) and more broad-spectrum antibiotics (P < 0.001). For the four most common diagnoses, the CDSS showed higher full guideline adherence (P < 0.001) and more frequently recommended Access agents. Conclusion: The CDSS demonstrated higher adherence to antibiotic guidelines than clinicians and greater alignment with WHO AWaRe classification. Further research is needed to evaluate prospective implementation and clinical impact in the ED.